What is Indivior Pharmaceuticals, Inc. 's free cash flow margin?

Indivior Pharmaceuticals, Inc. (INDV) reported free cash flow margin of -14.9% in Q1 2026.

What is the long-term trend for Indivior Pharmaceuticals, Inc. 's free cash flow margin?

Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's free cash flow margin has grown at a 174.0% compound annual growth rate (CAGR), from -1% to -7.5%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Indivior Pharmaceuticals, Inc. INDV Free cash flow margin

Free cash flow margin at other companies

AlkermesALKS

14.2%-17.6pp

JAN

Janus Living JAN

-29.7%—

Other financials

Income statement

See full

Revenue$317.0M+19.2%

Gross profit$277.0M+24.8%

Operating income$137.0M+108%

Net income$89.0M+89.4%

EPS (diluted)$0.69+81.6%

Balance sheet

See full

Cash & equivalents$175.0M-53.0%

Total debt$509.0M+37.6%

Total equity-$144.0M+49.5%

Total assets$1.2B-12.9%

Cash flow

See full

Operating cash flow-$9.0M-112%

CapEx$20.0M+300%

Free cash flow-$29.0M-141%

Valuation

See full

Market cap$4.53B+213%

Enterprise value$4.86B+242%

P/E18×—

P/S3.5×+2.3×

Profitability

See full

Gross margin81.3%+1.5pp

Operating margin25.8%+23.3pp

Net margin19.4%+18.9pp

Returns & leverage

See full

Return on equity-117%—

Debt / equity-3.5×—

Current ratio0.9×0.0×

Where this comes from

Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.

free cash flow/total revenue=-14.9%

Based on trailing twelve months.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's free cash flow margin?: Indivior Pharmaceuticals, Inc. (INDV) reported free cash flow margin of -14.9% in Q1 2026.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's free cash flow margin?: Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's free cash flow margin has grown at a 174.0% compound annual growth rate (CAGR), from -1% to -7.5%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.